Talphera (TLPH) Liabilities and Shareholders Equity (2010 - 2026)

Talphera's (TLPH) quarterly Liabilities and Shareholders Equity came in at $30.2 million in Q1 2026, up 101.1% year-on-year from $15.0 million in Q1 2025, and up 1.47% quarter-over-quarter from $29.7 million in Q4 2025.

Talphera (TLPH) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Talphera's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $30.2 million for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 101.1% year-over-year to $30.2 million in Q1 2026; TTM through Mar 2026 was $107.1 million, a 35.44% increase from a year earlier, with the FY2025 full-year figure at $29.7 million, up 62.97% from the prior year.
  • Liabilities and Shareholders Equity rose to $30.2 million in Q1 2026 per TLPH's latest filing, from $29.7 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $72.0 million in Q1 2022 and bottomed at $15.0 million in Q1 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $26.3 million (2023), against an average of $31.0 million.
  • Across the five-year window, Liabilities and Shareholders Equity tumbled 68.42% in 2023 and soared 101.1% in 2026, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $47.5 million in 2022, then tumbled by 57.05% to $20.4 million in 2023, then dropped by 10.59% to $18.2 million in 2024, then jumped by 62.97% to $29.7 million in 2025, then climbed by 1.47% to $30.2 million in 2026.
  • Per Business Quant, the three latest TLPH Liabilities and Shareholders Equity figures stand at $30.2 million (Q1 2026), $29.7 million (Q4 2025), and $30.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.40 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.04 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.15 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 98.91 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 6.71 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 69.30 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 36.83 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.91 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.22 Bn
10 Talphera 47.31 Mn 9.48 Mn - 30.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30.16 Mn
Dec 31, 2025 29.72 Mn
Sep 30, 2025 30.74 Mn
Jun 30, 2025 16.52 Mn
Mar 31, 2025 15.00 Mn
Dec 31, 2024 18.24 Mn
Sep 30, 2024 21.01 Mn
Jun 30, 2024 24.86 Mn
Mar 31, 2024 28.77 Mn
Dec 31, 2023 20.40 Mn
Sep 30, 2023 23.26 Mn
Jun 30, 2023 17.73 Mn
Mar 31, 2023 26.29 Mn
Dec 31, 2022 47.49 Mn
Sep 30, 2022 48.31 Mn
Jun 30, 2022 56.13 Mn
Mar 31, 2022 71.97 Mn
Dec 31, 2021 77.89 Mn
Sep 30, 2021 72.26 Mn
Jun 30, 2021 79.59 Mn